Lamotrigine as an Antidepressant Augmentation Agent in Treatment Refractory Unipolar Depression.

Trial Profile

Lamotrigine as an Antidepressant Augmentation Agent in Treatment Refractory Unipolar Depression.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 May 2014

At a glance

  • Drugs Lamotrigine (Primary) ; Paroxetine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top